Main Article Content

Combined oral administration of ethinylestradiol and levonorgestrel alters the expression of antioxidant and apoptotic markers in female rats


A.D Wusu
H.A Bankole
A.A Fatai
R.I Kanmodi
P.E Obasieke
T.D Wusu
O.K Afolabi

Abstract

The use of ethinylestradiol and levonorgestrel (E/L) for birth control may result in serious adverse effects. Herein, the effect of (E/L) on the expression of genes encoding antioxidant enzymes (superoxide dismutase (SOD) and Catalase (CAT)), and apoptotic regulator genes (B-cell lymphoma 2 (BCL-2), caspase 1 and 3) was evaluated. Thirty-two rats were randomly divided into four equal groups. Group A (Control) received 0.5% DMSO, Group B, C and D received 0.015, 0.030, and 0.060 mg of E/L orally and daily for 21 days respectively. RNA extracted from brain, liver and kidney were purified, and the genes amplified using RT-PCR. Following analysis of the intensity of the amplicon bands on 1.2% agarose, the gene's relative expression compared with the expression β-actin was determined. There was significant downregulation of SOD and CAT genes in the liver, brain and kidney in all groups treated with E/L compared to control. Caspase 1 and 3 expressions were significantly elevated by 3.8 and 3.5 folds, respectively in the brain at the lowest E/L concentration. Expression of BCL-2 was downregulated in the brain and kidney in animals administered E/L at all concentrations. These findings suggest that E/L could modulate the expression of antioxidant and apoptosis marker genes.


Keywords: Ethinylestradiol, Levonorgestrel, Contraceptive, Antioxidant, Apoptosis


Journal Identifiers


eISSN: 1597-6343
print ISSN: 2756-391X